Cable Viewer

Currently released so far... 12522 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AR AORC AF ASEC APER AS AMED AE AEMR AFIN AG AMGT APECO AU AJ AA ADM AGAO ABLD AL ASUP AID AADP ACOA ANET AY ASECKFRDCVISKIRFPHUMSMIGEG ARF ATRN APEC ASEAN AMBASSADOR AO ACS AM AZ ACABQ AGMT ABUD APCS AINF AORL AFFAIRS AFSI AFSN ACBAQ AFGHANISTAN ADANA AMCHAMS AIT ADPM AX ADCO AECL AMEX ACAO AODE ASCH AORG AGR AROC ASIG AND ARM AQ ATFN AC AUC ASEX AER AVERY AGRICULTURE AMG AFU AN ALOW
BR BO BM BA BK BU BB BL BY BF BEXP BTIO BD BE BH BG BRUSSELS BP BIDEN BT BC BX BILAT BN BBSR BTIU BWC BMGT
CASC CJAN CA CU CO CS CE CVIS CPAS CDG CI CH CBW CWC CMGT CD CM CDC CIA CG CNARC CN CONS CW CLINTON COE CT CIDA CR COUNTER CTR CSW CONDOLEEZZA CARICOM CB CY CL COM CICTE CFED COUNTRY CIS CROS CJUS CBSA CEUDA CLMT CAC CODEL COPUOS CIC CBE CHR CTM CVR CF COUNTERTERRORISM CITEL CLEARANCE CACS CAN CITT CARSON CACM CDB CV CAPC CKGR CBC
DR DEA DJ DA DHS DAO DCM DTRA DOD DOMESTIC DO DK DISENGAGEMENT DPRK DEPT DOE DS DE DEFENSE DEAX
ECON ELAB ETRD EINV EPET EAIR EIND ETTC EUR EUN ENRG EK EG ECPS EFIN EC EAID EUMEM EWWT ECIN ELTN EFIS EAGR EU EMIN ET ER ENIV ES EINT EZ EI EPA ERNG ENGR ENGY EXTERNAL ENERG EUREM ELN ENNP EFINECONCS ENVR ETRDEINVECINPGOVCS ELECTIONS ECA ETC EFTA EINVEFIN EN ECINECONCS EEPET ERD ENVI ETRC EXIM EURN ETRDEINVTINTCS ETRO EDU ETRN EAIG ECONCS ECONOMICS EAP ECONOMY ESA EINN ECONOMIC EIAR EXBS ECUN EINDETRD EREL EUC ESENV ECONEFIN ECIP EFIM EAIDS ETRDECONWTOCS EUNCH EINVETC EINVECONSENVCSJA ETRA
FR FI FDA FTAA FJ FBI FAC FARC FAO FTA FREEDOM FISO FOR FM FOREIGN FOI FAS FINR FINANCE FMLN FO
GG GM GV GR GAERC GA GE GOI GT GOV GH GTMO GY GANGS GAZA GERARD GL GF GCC GZ GTIP GLOBAL
HURI HR HEBRON HK HO HA HILLARY HSTC HU HUMAN HI HYMPSK HUMOR
IC IT IR IN ICAO IS ID ICRC IZ IAEA IMO IL IQ IRS INRA INRO IV ICJ IBRD IEFIN IACI INTELSAT IO ILC ICTY ITRA IDA ITU IRAQI ILO ITALY IIP INRB IRC IMF IAHRC IA IWC IPR ISRAELI INMARSAT INTERPOL INTERNAL ISLAMISTS INDO ITPHUM ITPGOV ITALIAN IBET INR IEA IZPREL IRAJ ITF IF ISRAEL ICTR IDP IGAD
JA JO JM JOHN JOSEPH JP JUS JAMES JOHNNIE
KDEM KCOR KCRM KMDR KPAO KWMN KNEI KNNP KJUS KISL KOMC KSUM KGHG KCRS KMCA KPKO KHLS KSCA KICC KIRF KPAL KWBG KN KIPR KPOA KV KDRG KBIO KTFN KBTR KFRD KCFE KE KPLS KSTC KTIP KTIA KS KHDP KHIV KCIP KTDB KZ KGIC KOLY KSEO KRVC KFLO KVPR KIRC KU KAWC KPRP KSEP KFLU KTER KBCT KSCI KUNR KRIM KWAC KG KMPI KOMS KSPR KFIN KCRCM KR KBTS KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KREC KLIG KSAF KACT KCOM KAID KPWR KNPP KDEMAF KSTH KOCI KNUP KIDE KPRV KWMM KX KMIG KAWK KRCM KVRP KPAONZ KNUC KNAR KRAD KNNPMNUC KERG KTBT KCFC KVIR KTEX KGIT KPAI KTLA KFSC KCSY KSAC KTRD KID KMRS KOM KMOC KJUST KGCC KREL KMFO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFTFN KO KNSD KHUM KSEC KCMR KCHG KICA KPIN KESS KDEV KCGC KWWMN KPAK KWNM KWMNCS KRFD KDDG KIFR KHSA KRGY
LY LG LH LE LO LI LTTE LU LA LAB LOG LT LABOR
MARR MASS MCAP MOPS MT MNUC MX MO MAR MTCRE MASSMNUC MARAD ML MY MAPP MEPN MD MZ MRCRE MI MA MAS MU MR MC MTCR MEETINGS MK MCC MG MIL MASC MV MIK MP MUCN MEDIA MPOS MERCOSUR MW MOPPS MTS MLS MILI MTRE MEPI MQADHAFI MAPS MEPP MILITARY MDC
NO NATO NZ NL NPT NI NU NSF NA NP NPG NSG NSFO NS NSC NE NK NPA NG NSSP NATIONAL NDP NASA NGO NR NIPP NAFTA NRR NEW NH NZUS NC NT NAR NV NORAD NATOPREL NW
OPRC OSCE OIIP OTRA OEXC OVIP OREP OPCW OPIC OECD OPDC OFDP OSCI OMIG ODIP OPAD OAS OVP OIE OFDA OCS OHUM OFFICIALS OBSP OTR OSAC ON OCII OES OIC
PGOV PREL PTER PK PHUM PINS PINR PL PREF PARM PM PBTS PO PE PEL PHSA PA PAO PBIO PAS POL PNAT PAK PSI PU PARMS POLITICS PHUMBA PROP PAIGH POLITICAL PARTIES POSTS PREO PMIL POGOV POV PNR PRL PG PINL PRGOV PALESTINIAN PAHO PROG PREFA PORG PTBS PUNE POLICY PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PP PS PY PTERE PGOF PKFK PSOE PEPR PPA PINT PMAR PRELP PSEPC PGOVE PINF PNG PGOC PFOR PCUL PLN POLINT PGGV PHALANAGE PARTY PGOVLO PHUS PDEM PECON PROV PHUMPREL PGIV PRAM PHUH PSA PHUMPGOV PF
QA
RS RU RP RW RO ROOD RSO RICE RM RUPREL RCMP REACTION REPORT REGION RIGHTS RF RFE RSP RIGHTSPOLMIL ROBERT RELATIONS
SOCI SCUL SW SZ SP SNAR SENV SY SR SMIG SU SF SO SA SARS SL SN SH SYR SC SG SNARN SEVN SCRS SAARC SI SHI SENVKGHG SHUM SPCE SYRIA SWE STEINBERG SIPRS ST SNARIZ SSA SK SPCVIS SOFA SIPDIS SAN SANC SEN SNARCS
TRGY TU TBIO TPHY TX TNGD TH TSPL TS TSPA TW TIP TZ TF TR TP TO TT TFIN TI TERRORISM TN THPY TD TL TV TC TINT TK TRSY TURKEY TBID TAGS
UK UNGA UP UN UNSC UNICEF UNESCO UY UNEP UV UNPUOS USTR US UNHRC UNAUS UZ UNMIK UNCSD USUN UNCHR UNDC UNHCR USNC UNO UG USEU USOAS UE UNDP UNC USPS USAID UNVIE UAE UNFICYP UNODC UNCHS UNIDROIT UNDESCO UNCHC UNCND
VE VC VT VZ VM VTIZ VTEG VN VTPREL VI VAT
WHTI WHO WBG WTRO WI WIPO WTO WHA WITH WS WTRQ WZ WFP WWARD WB WMO WEU WMD WA
XZ XV XF XA XW XQ XY XM XL XG XT XR XK XTAG XS XB XE XU XC XX XD XH XI
YM YI YE YMCS
ZB ZI ZP ZR ZO ZL ZF ZU ZJ ZEALAND ZK ZN ZA ZOELLICK ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`